BU Lead Enzyme Therapies, Germany

Business Unit Lead, Enzyme Therapies – Frankfurt, Germany Hybrid role Closing date: 6 July 2026 Reporting to the Country Manager Germany, the Business Unit Lead leads BioMarin’s Enzyme Therapies business in Germany. The role leads and develops a marketing and sales team to deliver revenue objectives and manage operating expenses for the Enzyme Therapies franchise spanning several products related to lysosomal and rare metabolic conditions. The Business Unit Lead works across three organisations: leading the local German Enzyme Therapies team, partnering with the Global Enzyme Therapies Business Unit on brand strategy, lifecycle, and indication expansion, and aligning with the regional EUCAN Enzyme Therapies organization on subregional brand plans, market access, and best‑practice sharing. Success requires strategic agility, business acumen, people leadership, and the ability to work collaboratively across a matrix organization. Patient centricity is central to BioMarin’s mission. The ideal candidate will be equally inspired by the needs of the lysosomal/rare metabolic disease community and driven to expand patient access to therapy. Key Responsibilities Define and execute the commercial strategy for the Enzyme Therapies franchise in Germany, translating global and EUCAN brand strategy into a localised plan that delivers revenue and patient‑access goals. Lead, coach, and develop the German Enzyme Therapies team; build capability, set ambitious but achievable targets, and manage performance. Own the German Enzyme Therapies budget; develop sales plans aligned to revenue goals and available resources, and manage spend with clear direction. Partner with the Global Enzyme Therapies BU on brand planning, competitive positioning, and lifecycle priorities; bring the German market perspective into global forums. Align with regional EUCAN Enzyme Therapies leadership on subregional brand plans, market access strategy, and cross‑country knowledge sharing. Drive cross‑functional collaboration with Market Access, Medical Affairs, Marketing, Patient Advocacy, and Commercial Operations to ensure coordinated execution. Spend time in the field with customers and KOLs, gathering insight and acting as the “voice of the customer” back into brand and regional teams. Build and maintain strong relationships with key opinion leaders, treating centers, and the patient community. Ensure all activities are conducted in full compliance with BioMarin policies, local regulations, and industry codes, role‑modeling the highest standards of ethics and integrity. Experience & Qualifications Significant pharmaceutical/biotech commercial experience (5+ years), including field sales management and leadership of teams. Proven track record in rare disease, specialty, or innovative medicines; experience in lysosomal diseases, paediatrics, endocrinology, or related therapeutic areas is a strong advantage. Demonstrated people‑leadership and management expertise; hiring, building, developing, and motivating commercial teams. Strong business acumen and budget ownership; results‑oriented with a sense of urgency and the judgment to adjust when goals are not met. Ability to operate effectively in a matrix environment, influencing and gaining cooperation without direct authority. Comfortable in an entrepreneurial, lean commercial environment, with an understanding of the constraints of a focused rare‑disease organization. Excellent communication and presentation skills; able to build credibility with KOLs, payers, and internal stakeholders. Deep commitment to compliance and to patient advocacy on behalf of the metabolic diseases community. Fluent German and English (written and spoken). Willingness to travel. Equal Opportunity Employer / Veterans / Disabled An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. #J-18808-Ljbffr BioMarin Pharmaceutical Inc.